Toronto, Canada

Methvin Issac



Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 14(Granted Patents)


Location History:

  • Etobicoke, CA (2003)
  • Toronto, CA (2011)

Company Filing History:


Years Active: 2003-2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Methvin Issac: Innovator in Neurological Treatments

Introduction

Methvin Issac is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of medicine, particularly in the treatment of neurological disorders. With a total of 2 patents, his work focuses on innovative compounds that address various health issues.

Latest Patents

Issac's latest patents include groundbreaking research on fluorinated compounds. These compounds, described by the formula I, are useful in the treatment of epilepsy, neuropathic pain, acute and chronic inflammatory pain, migraine, tardive dyskinesia, and other related CNS disorders. Additionally, he has developed N-alkylamino-heterocyclic compounds specifically for the treatment of migraine, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Methvin Issac has worked with prominent companies in the pharmaceutical industry. He has been associated with NPS Allelix Corporation and NPS Pharmaceuticals, Inc., where he contributed to the development of innovative treatments. His expertise and dedication have positioned him as a valuable asset in the field of medical research.

Collaborations

Issac has collaborated with talented individuals in his field, including Abdelmalik Slassi and Tao Xin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Methvin Issac's contributions to the field of neurological treatments through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the medical community positively, paving the way for future advancements in treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…